Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection
US7655479B2 · kind B2 · utility
11Cited by
3References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 30, 2005 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Nov 26, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/588
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Luminescent semiconductor quantum dots (QDs) conjugated with biomolecules to serve as sensitive probes for early detection of the cancer cells, specifically for ovarian cancer and lung cancer, which represents the most lethal malignancies. The luminescence characterization of the bin-conjugated QDs with cancer specific antigens using linkage molecules. Photo-enhancement is measured at various laser density power, temperatures and laser wavelengths.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.